Fibrocell Science: Detailed Company Information & Corporate Profile
Contact top employees from
Fibrocell Science
Summary
The business currently specializes in Biotechnology area. The company has 10-50 employees. Register with SignalHire to connect with Fibrocell Science employees and management.
| Fibrocell Science Website | fibrocell.com |
| Social Links |   |
| Phone Number | (484)713-6000 |
| Industries | |
| Fibrocell Science Headquarters address | 405 Eagleview Blvd, Exton, PA, 19341 US |
| Company Size | 10-50 employees |
| Specialties | autologous fibroblast cell therapy, gene therapy, personalized biologics |
Workforce Turnover
Length of Employment
Fibrocell Science's workforce includes employees across a wide range of tenure levels.
12% have been with the company for 5 to 7 years18% have been with the company for 8 to 10 years71% have been with the company for more than 11 yearsContact top employees from
Fibrocell Science
Nejla AbbedDirector of Sales and Customer Care
Alexander CyrQuality Control Associate
Doug SwirskyChairman Of The Board
Garrett GincleyManager, Cell Culture Production
Kathleen HorzempaDirector, Clinical Development
Companies Similar to Fibrocell Science
Fibrocell Science Corporate Information: FAQ
Fibrocell Science operates in the Biotech industries. More details can be found on the official website: fibrocell.com.
Fibrocell Science has offices located in Exton, US.
The headquarters of Fibrocell Science are located in Exton, United States.
You can contact Fibrocell Science by phone at (484)713-6000.
Fibrocell Science currently employs 10-50 people.
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
